Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children
Coronavirus,Coronavirus Vaccine,Pfizer,Children
From the Center
AllSides Media Bias Rating: Center
The Pfizer (PFE.N)/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
ICE Detains Conservative Influencer Milo Yiannopoulos in Louisiana
August 28th, 2026
Headline Roundup
USAID Report Claims Over 100 UNRWA Employees Participated in October 7 Attacks
August 28th, 2026
Bias
Will Data Centers Create Blackouts? Examining Media Bias and Misinformation on The Tucker Carlson Show
Julie Mastrine
August 28th, 2026
